-
CDC makes effort to reduce antibiotic overprescribing
Katina Hernandez Medical & Allied HealthcareThe overprescription of antibiotics in the U.S. is not a new phenomenon, and experts have warned healthcare providers about the dangerous implications for years. Despite these warnings, overprescribing persists, so the Centers for Disease Control and Prevention (CDC) and the American College of Physicians have just issued some new advice specifically aimed at curbing antibiotic use for acute respiratory tract infections.
-
Consumers fight back against rising pharmaceutical prices
Dr. Abimbola Farinde PharmaceuticalThe topic of escalating drug prices has been an ever-present focus for American consumers and drug companies. Pharmaceutical companies claim high prices are a necessary part of drug development, but consumers view them to be both unjust and unfair. As a result, there has been an ongoing debate between pharmaceutical companies and state legislators when it comes to current drug prices and what the future holds for many Americans who depend on these drugs.
-
Technology and medicine: New treatments for diabetes patients
Rosemary Sparacio Medical & Allied HealthcareThe technological revolution continues to foster advances in medicine at an increasingly rapid rate. In diabetes treatment, monitoring and care, state-of-the-art "gadgets" have made the management of this disease easier and allowed and encouraged more compliance on the part of the patients.
-
State of Public Health 2016: Our achievements, our aspirations
Dr. Ebun O. Ebunlomo Healthcare AdministrationAs we welcome each new year, we also anticipate remarks from the president during the annual State of the Union Address, which often outlines our achievements as a nation in the past year and our focus for the new year. The 2016 State of the Union speech by President Barack Obama was particularly anticipated by viewers this year, given that it was his last.
-
3 pharma advertising issues that must be addressed
Jason Poquette PharmaceuticalDavid Ogilvy, often hailed as the "Father of Advertising," once said, "Never write an advertisement which you wouldn't want your family to read. You wouldn't tell lies to your own wife. Don't tell them to mine." That's good advice. But advertising isn't just a concern for car manufacturers and computer companies, it concerns healthcare as well.
-
Despite slow start, it’s still too soon to declare this a mild flu…
Dorothy L. Tengler Medical & Allied HealthcareFlu season is unpredictable. Over a period of 30 years, between 1976 and 2006, annual estimates of flu-associated deaths in the United States ranged from a low of about 3,000 to a high of about 49,000 people.
-
My 5 pharmacist goals for 2016
Jason Poquette PharmaceuticalAs a practicing pharmacist in an outpatient setting, I always try to allow my real-life experience in healthcare inform my writing. My chair is no ivory tower. Most days my feet are planted firmly behind (or in front of) the counter. I work in what I like to think of as the "front lines" of pharmaceutical services: checking prescriptions and counseling patients on using their medications safely and effectively.
-
FDA approval of Empliciti provides another tool in battle against cancer
Dr. Abimbola Farinde PharmaceuticalMultiple myeloma is a type of blood cancer that can appear in infection-fighting cells. Identified in the bone marrow, the cancer is mainly incurable with about only half of diagnosed patients surviving for five years after given the diagnosis.
-
Finding balance for patients: Hospitals and marijuana
Christina Thielst Healthcare AdministrationStories abound about how marijuana has helped relieve symptoms in those who are seriously ill, and thousands of basic science studies provide the foundation for these claims. So it is not surprising that 23 states and the District of Columbia have passed legislation permitting cannabis use for some medical purposes.
-
My PBM Christmas wish list
Jason Poquette PharmaceuticalA recent report published by Applied Policy is urging for more regulation of the PBM industry, which controls upwards of 70 percent of the prescription business in our country. The document, entitled "Concerns Regarding the Pharmacy Benefit Management Industry," addresses issues like conflicts of interest, transparency and reimbursement strategies.
All Pharmaceutical Articles